Other Drugs Used to Treat Pain

Handbook of Veterinary Pain Management

Volumn , Issue , 2009, Pages 260-276

  Gaynor, James S ^a  

^a Animal Anesthesia and Pain Management Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 54149098884     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-032304679-4.10014-0     Document Type: Chapter

References (27)

1. Felsby S., Nielsen J., Arendt-Nielsen L., et al. NMDA receptor blockade in chronic neuropathic pain: a comparison of ketamine and magnesium chloride. Pain 1996, 64:283-291.
2. Wilder-Smith O.H., Arendt-Nielsen L., Gaumann D., et al. Sensory changes and pain after abdominal hysterectomy: a comparison of anesthetic supplementation with fentanyl versus magnesium or ketamine. Anesth Analg 1998, 86:95-101.
3. Mama KR, Golden AE, Monnet E et al: Plasma and cerebrospinal fluid concentrations and NMDA receptor binding activity associated with intraoperative administration of low-dose ketamine. In Proceedings 7th World Congress of Veterinary Anaesthesia, Berne 2000 p 78, 2000 (abstract).
4. Ren K., Dubner R. Central nervous system plasticity and persistent pain. J Orofac Pain 1999, 13:155-163. (review; 68 refs; discussion, pp 164-171).
5. Crosby V., Wilcock A., Corcoran R. The safety and efficacy of a single dose (500 mg or 1 g) of intravenous magnesium sulfate in neuropathic pain poorly responsive to strong opioid analgesics in patients with cancer. J Pain Symptom Manage 2000, 19:35-39.
6. Kroin J.S., McCarthy R.J., Von Roenn N., et al. Magnesium sulfate potentiates morphine antinociception at the spinal level. Anesth Analg 2000, 90:913-917.
7. Koinig H., Wallner T., Marhofer P., et al. Magnesium sulfate reduces intra- and postoperative analgesic requirements. Anesth Analg 1998, 87:206-210.
8. Mathews K.A. Nonsteroidal anti-inflammatory analgesics: indications and contraindications for pain management in dogs and cats. Vet Clin North Am Small Anim Pract 2000, 30:783-804.
9. Mathews K.A., Paley D.M., Foster R.A., et al. A comparison of ketorolac with flunixin, butorphanol, and oxymorphone in controlling postoperative pain in dogs. Can Vet J 1996, 37:557-567.
10. Popilskis S., Jordan D., Laurent L., et al. Comparison of ketorolac and oxymorphone on postoperative pain relief and neuroendocrine response in dogs. 6th ICVA 1997, 107.
11. Pasloske K., Renaud R., Burger J., et al. Pharmacokinetics of ketorolac after intravenous and oral single dose administration in dogs. J Vet Pharmacol Ther 1999, 22:314-319.
12. De Kock M., Crochet B., Morimont C., Scholtes J.L. Intravenous or epidural clonidine for intra and postoperative analgesia. Anesthesiology 1993, 79:525-531.
13. Minto C.F., Power I. New opioid analgesics: an update. Int Anesthesiol Clin 1997, 35:49-65. (review; 95 refs).
14. Lehmann K.A. Tramadol for the management of acute pain. Drugs 1994, 47(suppl 1):19-32. (review; 71 refs).
15. Sindrup S.H., Anderson G., Madsen C., et al. Tramadol relieves pain and allodynia in polyneuropathy: a randomised, double-blind, controlled trial. Pain 1999, 83:85-90.
16. Lintz W., Erlacin S., Frankus E., et al. [Biotransformation of tramadol in man and animal] (author's translation from German). Arzneimittelforschung 1981, 31:1932-1943.
17. Miranda H.F., Pinardi G. Antinociception, tolerance, and physical dependence comparison between morphine and tramadol. Pharmacol Biochem Behav 1998, 61:357-360.
18. Pud D., Eisenberg E., Spitzer A., et al. The NMDA receptor antagonist amantidine reduces surgical neuropathic pain in cancer patients: a double blind, randomized, placebo controlled trial. Pain 1998, 75:349-354.
19. Eisenberg E., Pud D. Can patients with chronic neuropathic pain be cured by acute administration of the NMDA receptor antagonist amantidine. Pain 1988, 74:337-339.
20. Radulovic L.L., Turck D., von Hodenberg A., et al. Disposition of gabapentin (neurontin) in mice, rats, dogs, and monkeys. Drug Metab Dispos 1995, 23:441-448.
21. Mao J., Chen L.L. Gabapentin in pain management. Anesth Analg 2000, 91:680-687.
22. Boileau C., Martel-Pelletier J., Brunet J., et al. Oral treatment with PD-0200347, an alpha2delta ligand, reduces the development of experimental osteoarthritis by inhibiting metalloproteinases and inducible nitric oxide synthase gene expression and synthesis in cartilage chondrocytes. Arthritis Rheum 2005, 52:488-500.
23. Mahani S.E., Motamedi F., Ahmadiani A. Involvement of hypothalamic adrenal axis on the nifedipine-induced antinociception and tolerance in rats. Pharmacol Biochem Behav 2006, 85:422-427.
24. Canapp S.O., McLaughlin R.M., Hoskinson J.J., et al. Scintigraphic evaluation of glucosamine hydrochloride and chondroitin sulfate as a treatment for acute synovitis in dogs. Am J Vet Res 1999, 60:1552-1557.
25. Lawson B.R., Belkowski S.M., Whitesides J.F., et al. Immunomodulation of murine collagen-induced arthritis by N, N-dimethylglycine and a preparation of Perna canaliculus. BMC Complement Altern Med 2007, 7:20.
26. Hurley L. New research and clinical report on the use of Perna canaliculus in the management of arthritis. Townsend Letter for Doctors and Patients 2000, 99-111.
27. Martinez SA, McCormick DJ, Powers MY et al: The effect of Glyco-Flex III on a stable stifle osteoarthritis model in dogs: a pilot study. Presented at the Veterinary Orthopedic Society Annual Scientific Meeting, Sun Valley, Idaho, 2007.